Apoptosis, tumor cell proliferation and angiogenesis as prognostic factor in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004
The growth of lung cancer cells is progressed by G-CSF and M-CSF due to activation of angiogenesis Source: Eur Respir J 2003; 22: Suppl. 45, 224s Year: 2003
P2X7 receptor regulates cell survival, inflammation processes and proliferation of lung carcinoma cells Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019
KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020
Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro Source: Eur Respir J 2002; 20: 1449-1456 Year: 2002
Bile acid receptor accelerates to the lung cancer process induced by lung fibroblast-tumor cells interaction, with high activation of phosphorylated STAT3 and alteration of cytokine secretion Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017
Circulating fibrocytes depletion results in reduced lung tumor growth and metastasis by modulating macrophage phenotype, angiogenesis and endothelin system Source: ERS Lung Science Conference 2017 Year: 2017
NTHi-promoted proliferation of K-ras-induced early lung cancer lesions is fully dependent on Toll-like receptor signaling Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017
Inhibition of insulin-like growth factor type I (IGF-I) gene in A549 human lung cancer cell line enhances cell apoptosis and causes phenotype changes relevant to increased tumor susceptibility to immune system Source: Eur Respir J 2007; 30: Suppl. 51, 715s Year: 2007
Effects of chemotherapeutic drugs and TRAIL (tumor necrosis factor-related apoptosis inducing ligand) on the non-small lung cancer cells Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Interleukin-8 stimulates human airway epithelial cell proliferation through EGFR transactivation Source: Eur Respir J 2003; 22: Suppl. 45, 561s Year: 2003
Interleukin-17 enhances the net angiogenic potential and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis Source: Eur Respir J 2004; 24: Suppl. 48, 79s Year: 2004
Inverse correlation between the expression of vascular endothelial growth factor and infiltration of dendritic cells and their influence on the prognosis of nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 13s Year: 2002
Dimethylfumarate reduces growth factor- and cytokine-induced IL-6 release from human lung fibroblasts: role of (NF)-κB Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008
EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020
Expression of tumor necrosis factor receptor 2 in human non-small cell lung cancer and its role as a potential prognostic biomarker Source: International Congress 2019 – Biology of lung cancer Year: 2019
Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses tumor-specific T cell immunity Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Differential roles of tumour necrosis factor receptors in a murine model of acid induced lung injury Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008
Differences in growth signaling pathway activation in small cell and non-small cell carcinomas of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 326s Year: 2006
Effects of endothelin-1 on MAPK activation, IL-6 production and cell proliferation in normal human lung fibroblasts Source: Eur Respir J 2004; 24: Suppl. 48, 454s Year: 2004